APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herceptin (Trastuzumab)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Herceptin (Trastuzumab) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchHerceptin (Trastuzumab) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Herceptin (Trastuzumab) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Herceptin (Trastuzumab) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herceptin (Trastuzumab) Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Herceptin (Trastuzumab) Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Herceptin (Trastuzumab) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Herceptin (Trastuzumab) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Herceptin (Trastuzumab) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herceptin (Trastuzumab) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Herceptin (Trastuzumab) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herceptin (Trastuzumab) include Teva Pharmaceutical, Novartis AG, Merck, Mylan, Pfizer, Amgen, Samsung Bioepis, Roche Diagnostics and Mundipharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Herceptin (Trastuzumab) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Herceptin (Trastuzumab) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Herceptin (Trastuzumab) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Herceptin (Trastuzumab) market size, projected growth trends, production technologies, key applications, and end-use industries.

Herceptin (Trastuzumab) Segment by Company

Teva Pharmaceutical

Novartis AG

Merck

Mylan

Pfizer

Amgen

Samsung Bioepis

Roche Diagnostics

Mundipharma

Mabion

InvivoGen

Genentech

Celltrion

Bio-Techne

Biocon Limited

AryoGen Biopharma

Abnova Corporation

Herceptin (Trastuzumab) Segment by Type

Breast Cancer

Stomach Cancer

Others

Herceptin (Trastuzumab) Segment by Application

Hospital

Medical Center

Herceptin (Trastuzumab) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herceptin (Trastuzumab) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herceptin (Trastuzumab) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herceptin (Trastuzumab).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Herceptin (Trastuzumab) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herceptin (Trastuzumab) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Herceptin (Trastuzumab) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Herceptin (Trastuzumab) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Herceptin (Trastuzumab) Industry Trends Table 2. Herceptin (Trastuzumab) Industry Drivers Table 3. Herceptin (Trastuzumab) Industry Opportunities and Challenges Table 4. Herceptin (Trastuzumab) Industry Restraints Table 5. Global Herceptin (Trastuzumab) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Herceptin (Trastuzumab) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers Table 9. Global Herceptin (Trastuzumab) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Herceptin (Trastuzumab) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Herceptin (Trastuzumab) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Herceptin (Trastuzumab) Manufacturers, Product Type & Application Table 13. Global Herceptin (Trastuzumab) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Herceptin (Trastuzumab) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Breast Cancer Table 17. Major Manufacturers of Stomach Cancer Table 18. Major Manufacturers of Others Table 19. Global Herceptin (Trastuzumab) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 21. Global Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 22. Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2026) Table 23. Global Herceptin (Trastuzumab) Sales Market Share by Type (2027-2032) Table 24. Global Herceptin (Trastuzumab) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (K Units) Table 26. Global Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (K Units) Table 27. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2026) Table 28. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Medical Center Table 31. Global Herceptin (Trastuzumab) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 33. Global Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 34. Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2026) Table 35. Global Herceptin (Trastuzumab) Sales Market Share by Application (2027-2032) Table 36. Global Herceptin (Trastuzumab) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (K Units) Table 38. Global Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (K Units) Table 39. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2026) Table 40. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2027-2032) Table 41. Global Herceptin (Trastuzumab) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Herceptin (Trastuzumab) Sales by Region (2021-2026) & (K Units) Table 43. Global Herceptin (Trastuzumab) Sales Market Share by Region (2021-2026) Table 44. Global Herceptin (Trastuzumab) Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Herceptin (Trastuzumab) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 48. North America Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 49. Europe Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 51. Europe Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 58. Global Herceptin (Trastuzumab) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Herceptin (Trastuzumab) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Herceptin (Trastuzumab) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2021-2026) Table 62. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis AG Herceptin (Trastuzumab) Product Portfolio Table 72. Novartis AG Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck Herceptin (Trastuzumab) Product Portfolio Table 77. Merck Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Herceptin (Trastuzumab) Product Portfolio Table 82. Mylan Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Herceptin (Trastuzumab) Product Portfolio Table 87. Pfizer Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Amgen Herceptin (Trastuzumab) Product Portfolio Table 92. Amgen Recent Development Table 93. Samsung Bioepis Company Information Table 94. Samsung Bioepis Business Overview Table 95. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio Table 97. Samsung Bioepis Recent Development Table 98. Roche Diagnostics Company Information Table 99. Roche Diagnostics Business Overview Table 100. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio Table 102. Roche Diagnostics Recent Development Table 103. Mundipharma Company Information Table 104. Mundipharma Business Overview Table 105. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Mundipharma Herceptin (Trastuzumab) Product Portfolio Table 107. Mundipharma Recent Development Table 108. Mabion Company Information Table 109. Mabion Business Overview Table 110. Mabion Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Mabion Herceptin (Trastuzumab) Product Portfolio Table 112. Mabion Recent Development Table 113. InvivoGen Company Information Table 114. InvivoGen Business Overview Table 115. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. InvivoGen Herceptin (Trastuzumab) Product Portfolio Table 117. InvivoGen Recent Development Table 118. Genentech Company Information Table 119. Genentech Business Overview Table 120. Genentech Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Genentech Herceptin (Trastuzumab) Product Portfolio Table 122. Genentech Recent Development Table 123. Celltrion Company Information Table 124. Celltrion Business Overview Table 125. Celltrion Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Celltrion Herceptin (Trastuzumab) Product Portfolio Table 127. Celltrion Recent Development Table 128. Bio-Techne Company Information Table 129. Bio-Techne Business Overview Table 130. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bio-Techne Herceptin (Trastuzumab) Product Portfolio Table 132. Bio-Techne Recent Development Table 133. Biocon Limited Company Information Table 134. Biocon Limited Business Overview Table 135. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Biocon Limited Herceptin (Trastuzumab) Product Portfolio Table 137. Biocon Limited Recent Development Table 138. AryoGen Biopharma Company Information Table 139. AryoGen Biopharma Business Overview Table 140. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio Table 142. AryoGen Biopharma Recent Development Table 143. Abnova Corporation Company Information Table 144. Abnova Corporation Business Overview Table 145. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Abnova Corporation Herceptin (Trastuzumab) Product Portfolio Table 147. Abnova Corporation Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Herceptin (Trastuzumab) Distributors List Table 151. Herceptin (Trastuzumab) Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Herceptin (Trastuzumab) Product Image Figure 2. Global Herceptin (Trastuzumab) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herceptin (Trastuzumab) Market Size (2021-2032) & (US$ Million) Figure 4. Global Herceptin (Trastuzumab) Sales (2021-2032) & (K Units) Figure 5. Global Herceptin (Trastuzumab) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Herceptin (Trastuzumab) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Breast Cancer Image Figure 9. Stomach Cancer Image Figure 10. Others Image Figure 11. Global Herceptin (Trastuzumab) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Herceptin (Trastuzumab) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2032) Figure 14. Global Herceptin (Trastuzumab) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Herceptin (Trastuzumab) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Medical Center Image Figure 19. Global Herceptin (Trastuzumab) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Herceptin (Trastuzumab) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2032) Figure 22. Global Herceptin (Trastuzumab) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Herceptin (Trastuzumab) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2032) Figure 25. North America Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Herceptin (Trastuzumab) Sales Market Share by Country (2021-2032) Figure 27. U.S. Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2021-2032) Figure 32. Germany Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Country (2021-2032) Figure 39. China Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Herceptin (Trastuzumab) Sales Market Share by Country (2021-2032) Figure 47. Brazil Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Herceptin (Trastuzumab) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Herceptin (Trastuzumab) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Herceptin (Trastuzumab) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Figure 58. North America Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Herceptin (Trastuzumab) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Herceptin (Trastuzumab) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Breast Cancer
  • Stomach Cancer
  • Others
Applications
  • Hospital
  • Medical Center
Companies covered
  • Teva Pharmaceutical
  • Novartis AG
  • Merck
  • Mylan
  • Pfizer
  • Amgen
  • Samsung Bioepis
  • Roche Diagnostics
  • Mundipharma
  • Mabion
  • InvivoGen
  • Genentech
  • Celltrion
  • Bio-Techne
  • Biocon Limited
  • AryoGen Biopharma
  • Abnova Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Herceptin (Trastuzumab) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Herceptin (Trastuzumab) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Herceptin (Trastuzumab) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Herceptin (Trastuzumab) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Herceptin (Trastuzumab) Market Dynamics
  1. 2.1 Herceptin (Trastuzumab) Industry Trends
  2. 2.2 Herceptin (Trastuzumab) Industry Drivers
  3. 2.3 Herceptin (Trastuzumab) Industry Opportunities and Challenges
  4. 2.4 Herceptin (Trastuzumab) Industry Restraints
3 Herceptin (Trastuzumab) Market by Manufacturers
  1. 3.1 Global Herceptin (Trastuzumab) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Herceptin (Trastuzumab) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Herceptin (Trastuzumab) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Herceptin (Trastuzumab) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herceptin (Trastuzumab) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Herceptin (Trastuzumab) Manufacturers, Product Type & Application
  7. 3.7 Global Herceptin (Trastuzumab) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herceptin (Trastuzumab) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herceptin (Trastuzumab) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herceptin (Trastuzumab) Tier 1, Tier 2, and Tier 3
4 Herceptin (Trastuzumab) Market by Type
  1. 4.1 Herceptin (Trastuzumab) Type Introduction
  2. 4.1.1 Breast Cancer
  3. 4.1.2 Stomach Cancer
  4. 4.1.3 Others
  5. 4.2 Global Herceptin (Trastuzumab) Sales by Type
  6. 4.2.1 Global Herceptin (Trastuzumab) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Herceptin (Trastuzumab) Sales by Type (2021-2032)
  8. 4.2.3 Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Herceptin (Trastuzumab) Revenue by Type
  10. 4.3.1 Global Herceptin (Trastuzumab) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  12. 4.3.3 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2032)
5 Herceptin (Trastuzumab) Market by Application
  1. 5.1 Herceptin (Trastuzumab) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Medical Center
  4. 5.2 Global Herceptin (Trastuzumab) Sales by Application
  5. 5.2.1 Global Herceptin (Trastuzumab) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Herceptin (Trastuzumab) Sales by Application (2021-2032)
  7. 5.2.3 Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Herceptin (Trastuzumab) Revenue by Application
  9. 5.3.1 Global Herceptin (Trastuzumab) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  11. 5.3.3 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2032)
6 Global Herceptin (Trastuzumab) Sales by Region
  1. 6.1 Global Herceptin (Trastuzumab) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Herceptin (Trastuzumab) Sales by Region (2021-2032)
  3. 6.2.1 Global Herceptin (Trastuzumab) Sales by Region (2021-2026)
  4. 6.2.2 Global Herceptin (Trastuzumab) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Herceptin (Trastuzumab) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Herceptin (Trastuzumab) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Herceptin (Trastuzumab) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Herceptin (Trastuzumab) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Herceptin (Trastuzumab) Revenue by Region
  1. 7.1 Global Herceptin (Trastuzumab) Revenue by Region
  2. 7.1.1 Global Herceptin (Trastuzumab) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Herceptin (Trastuzumab) Revenue by Region (2021-2026)
  4. 7.1.3 Global Herceptin (Trastuzumab) Revenue by Region (2027-2032)
  5. 7.1.4 Global Herceptin (Trastuzumab) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Herceptin (Trastuzumab) Revenue (2021-2032)
  8. 7.2.2 North America Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Herceptin (Trastuzumab) Revenue (2021-2032)
  11. 7.3.2 Europe Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Herceptin (Trastuzumab) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Herceptin (Trastuzumab) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Herceptin (Trastuzumab) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Herceptin (Trastuzumab) Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Herceptin (Trastuzumab) Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Herceptin (Trastuzumab) Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Herceptin (Trastuzumab) Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Herceptin (Trastuzumab) Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 Samsung Bioepis
  38. 8.7.1 Samsung Bioepis Company Information
  39. 8.7.2 Samsung Bioepis Business Overview
  40. 8.7.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio
  42. 8.7.5 Samsung Bioepis Recent Developments
  43. 8.8 Roche Diagnostics
  44. 8.8.1 Roche Diagnostics Company Information
  45. 8.8.2 Roche Diagnostics Business Overview
  46. 8.8.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio
  48. 8.8.5 Roche Diagnostics Recent Developments
  49. 8.9 Mundipharma
  50. 8.9.1 Mundipharma Company Information
  51. 8.9.2 Mundipharma Business Overview
  52. 8.9.3 Mundipharma Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mundipharma Herceptin (Trastuzumab) Product Portfolio
  54. 8.9.5 Mundipharma Recent Developments
  55. 8.10 Mabion
  56. 8.10.1 Mabion Company Information
  57. 8.10.2 Mabion Business Overview
  58. 8.10.3 Mabion Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mabion Herceptin (Trastuzumab) Product Portfolio
  60. 8.10.5 Mabion Recent Developments
  61. 8.11 InvivoGen
  62. 8.11.1 InvivoGen Company Information
  63. 8.11.2 InvivoGen Business Overview
  64. 8.11.3 InvivoGen Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 InvivoGen Herceptin (Trastuzumab) Product Portfolio
  66. 8.11.5 InvivoGen Recent Developments
  67. 8.12 Genentech
  68. 8.12.1 Genentech Company Information
  69. 8.12.2 Genentech Business Overview
  70. 8.12.3 Genentech Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech Herceptin (Trastuzumab) Product Portfolio
  72. 8.12.5 Genentech Recent Developments
  73. 8.13 Celltrion
  74. 8.13.1 Celltrion Company Information
  75. 8.13.2 Celltrion Business Overview
  76. 8.13.3 Celltrion Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Celltrion Herceptin (Trastuzumab) Product Portfolio
  78. 8.13.5 Celltrion Recent Developments
  79. 8.14 Bio-Techne
  80. 8.14.1 Bio-Techne Company Information
  81. 8.14.2 Bio-Techne Business Overview
  82. 8.14.3 Bio-Techne Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Techne Herceptin (Trastuzumab) Product Portfolio
  84. 8.14.5 Bio-Techne Recent Developments
  85. 8.15 Biocon Limited
  86. 8.15.1 Biocon Limited Company Information
  87. 8.15.2 Biocon Limited Business Overview
  88. 8.15.3 Biocon Limited Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biocon Limited Herceptin (Trastuzumab) Product Portfolio
  90. 8.15.5 Biocon Limited Recent Developments
  91. 8.16 AryoGen Biopharma
  92. 8.16.1 AryoGen Biopharma Company Information
  93. 8.16.2 AryoGen Biopharma Business Overview
  94. 8.16.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio
  96. 8.16.5 AryoGen Biopharma Recent Developments
  97. 8.17 Abnova Corporation
  98. 8.17.1 Abnova Corporation Company Information
  99. 8.17.2 Abnova Corporation Business Overview
  100. 8.17.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abnova Corporation Herceptin (Trastuzumab) Product Portfolio
  102. 8.17.5 Abnova Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Herceptin (Trastuzumab) Value Chain Analysis
  2. 9.1.1 Herceptin (Trastuzumab) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Herceptin (Trastuzumab) Production Mode & Process
  6. 9.2 Herceptin (Trastuzumab) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Herceptin (Trastuzumab) Distributors
  9. 9.2.3 Herceptin (Trastuzumab) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst